Gerresheimer (GXI) Given a €55.00 Price Target at Hauck & Aufhaeuser

Hauck & Aufhaeuser set a €55.00 ($65.48) target price on Gerresheimer (ETR:GXI) in a research note published on Wednesday morning. The brokerage currently has a sell rating on the stock.

Other research analysts have also recently issued reports about the company. Commerzbank set a €77.00 ($91.67) price objective on Gerresheimer and gave the company a buy rating in a research note on Thursday, September 28th. JPMorgan Chase & Co. set a €99.40 ($118.33) price objective on Gerresheimer and gave the company a buy rating in a research note on Wednesday, October 11th. Berenberg Bank set a €75.00 ($89.29) price objective on Gerresheimer and gave the company a buy rating in a research note on Wednesday, October 11th. Credit Suisse Group set a €80.00 ($95.24) price objective on Gerresheimer and gave the company a buy rating in a research note on Tuesday, October 10th. Finally, set a €65.00 ($77.38) price objective on Gerresheimer and gave the company a neutral rating in a research note on Tuesday, October 17th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average price target of €70.62 ($84.07).

Shares of Gerresheimer (ETR:GXI) traded up €0.60 ($0.71) during trading hours on Wednesday, hitting €71.55 ($85.18). The stock had a trading volume of 152,205 shares, compared to its average volume of 118,030. Gerresheimer has a 52-week low of €59.97 ($71.39) and a 52-week high of €78.25 ($93.15). The company has a market capitalization of $2,250.00 and a PE ratio of 50.74.

COPYRIGHT VIOLATION NOTICE: “Gerresheimer (GXI) Given a €55.00 Price Target at Hauck & Aufhaeuser” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.com-unik.info/2018/01/11/gerresheimer-gxi-given-a-55-00-price-target-at-hauck-aufhaeuser.html.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit